News
CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...
CVS Caremark must now shoulder nearly $290 million in damages and penalties after being found complicit in a Medicare Part D ...
Increased use of GLP-1 and services for cancer and mental health are contributing factors, says Business Group on Health.
6h
Zacks Investment Research on MSNGILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
Shares of Gilead Sciences, Inc. (GILD) tumbled 2.2% on Aug. 21, after pharmacy benefit manager CVS Health (CVS) decided not ...
17h
StockStory.org on MSNQ2 Rundown: The Ensign Group (NASDAQ:ENSG) Vs Other Healthcare Providers & Services Stocks
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a ...
TAMPA, FLORIDA / ACCESS Newswire / August 20, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) (“Wellgistics Health” or the “Company”), a leader in next-generation pharmaceutical distribution, digital ...
As president of the Pennsylvania State Grange, I hear the same concerns from families, farmers, and small business owners across our state: prescription drug costs are too high, and the ...
As president of the Pennsylvania State Grange, I hear the same concerns from families, farmers, and small business owners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results